Cargando…

Development of fiber optic in vitro release testing method for dexamethasone release from the oil solutions

For many parenteral drugs, there is still no standardized method for in vitro release (IVR) testing available. This article presents the development of a new IVR method for oil solutions using a dialysis membrane and USP II apparatus coupled to a fiber optic UV-Vis spectrometer. Experiments were per...

Descripción completa

Detalles Bibliográficos
Autores principales: Kozlina, Filip, Meštrović, Ivan, Novak, Viktor, Marjanović, Nikola, Cetina-Čižmek, Biserka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Association of Physical Chemists 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793461/
https://www.ncbi.nlm.nih.gov/pubmed/36578560
http://dx.doi.org/10.5599/admet.1465
_version_ 1784859852063899648
author Kozlina, Filip
Meštrović, Ivan
Novak, Viktor
Marjanović, Nikola
Cetina-Čižmek, Biserka
author_facet Kozlina, Filip
Meštrović, Ivan
Novak, Viktor
Marjanović, Nikola
Cetina-Čižmek, Biserka
author_sort Kozlina, Filip
collection PubMed
description For many parenteral drugs, there is still no standardized method for in vitro release (IVR) testing available. This article presents the development of a new IVR method for oil solutions using a dialysis membrane and USP II apparatus coupled to a fiber optic UV-Vis spectrometer. Experiments were performed using dexamethasone formulations containing castor oil as a solvent with the addition of cosolvents, 20 % (v/v) of isopropanol or Capryol(®) 90. Based on solubility testing results, castor oil was chosen as the best solvent amongst other vegetable oils, while a significant increase in solubility was obtained by adding either of the two cosolvents. Partitioning experiments were performed to ensure these formulations could achieve prolonged drug release. IVR testing was performed with model formulations and critical test parameters were varied in order to examine the method’s sensitivity. The developed method was sensitive to temperature and stirring rate, while coupling the USP II apparatus with a fiber optic UV-Vis spectrometer enabled complete automation. Moreover, due to the interference of excipients on fiber optic detection of dexamethasone during the release testing, derivative spectroscopy was successfully introduced for the elimination of the interference. The developed IVR method described herein could be useful in preformulation investigations and the early development of novel formulations.
format Online
Article
Text
id pubmed-9793461
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher International Association of Physical Chemists
record_format MEDLINE/PubMed
spelling pubmed-97934612022-12-27 Development of fiber optic in vitro release testing method for dexamethasone release from the oil solutions Kozlina, Filip Meštrović, Ivan Novak, Viktor Marjanović, Nikola Cetina-Čižmek, Biserka ADMET DMPK Original Scientific Paper For many parenteral drugs, there is still no standardized method for in vitro release (IVR) testing available. This article presents the development of a new IVR method for oil solutions using a dialysis membrane and USP II apparatus coupled to a fiber optic UV-Vis spectrometer. Experiments were performed using dexamethasone formulations containing castor oil as a solvent with the addition of cosolvents, 20 % (v/v) of isopropanol or Capryol(®) 90. Based on solubility testing results, castor oil was chosen as the best solvent amongst other vegetable oils, while a significant increase in solubility was obtained by adding either of the two cosolvents. Partitioning experiments were performed to ensure these formulations could achieve prolonged drug release. IVR testing was performed with model formulations and critical test parameters were varied in order to examine the method’s sensitivity. The developed method was sensitive to temperature and stirring rate, while coupling the USP II apparatus with a fiber optic UV-Vis spectrometer enabled complete automation. Moreover, due to the interference of excipients on fiber optic detection of dexamethasone during the release testing, derivative spectroscopy was successfully introduced for the elimination of the interference. The developed IVR method described herein could be useful in preformulation investigations and the early development of novel formulations. International Association of Physical Chemists 2022-10-11 /pmc/articles/PMC9793461/ /pubmed/36578560 http://dx.doi.org/10.5599/admet.1465 Text en Copyright © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Original Scientific Paper
Kozlina, Filip
Meštrović, Ivan
Novak, Viktor
Marjanović, Nikola
Cetina-Čižmek, Biserka
Development of fiber optic in vitro release testing method for dexamethasone release from the oil solutions
title Development of fiber optic in vitro release testing method for dexamethasone release from the oil solutions
title_full Development of fiber optic in vitro release testing method for dexamethasone release from the oil solutions
title_fullStr Development of fiber optic in vitro release testing method for dexamethasone release from the oil solutions
title_full_unstemmed Development of fiber optic in vitro release testing method for dexamethasone release from the oil solutions
title_short Development of fiber optic in vitro release testing method for dexamethasone release from the oil solutions
title_sort development of fiber optic in vitro release testing method for dexamethasone release from the oil solutions
topic Original Scientific Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793461/
https://www.ncbi.nlm.nih.gov/pubmed/36578560
http://dx.doi.org/10.5599/admet.1465
work_keys_str_mv AT kozlinafilip developmentoffiberopticinvitroreleasetestingmethodfordexamethasonereleasefromtheoilsolutions
AT mestrovicivan developmentoffiberopticinvitroreleasetestingmethodfordexamethasonereleasefromtheoilsolutions
AT novakviktor developmentoffiberopticinvitroreleasetestingmethodfordexamethasonereleasefromtheoilsolutions
AT marjanovicnikola developmentoffiberopticinvitroreleasetestingmethodfordexamethasonereleasefromtheoilsolutions
AT cetinacizmekbiserka developmentoffiberopticinvitroreleasetestingmethodfordexamethasonereleasefromtheoilsolutions